Leticia Oliveira‐Ferrer

3.2k total citations
76 papers, 2.3k citations indexed

About

Leticia Oliveira‐Ferrer is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Leticia Oliveira‐Ferrer has authored 76 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 22 papers in Oncology and 19 papers in Immunology. Recurrent topics in Leticia Oliveira‐Ferrer's work include Glycosylation and Glycoproteins Research (14 papers), Angiogenesis and VEGF in Cancer (12 papers) and Galectins and Cancer Biology (12 papers). Leticia Oliveira‐Ferrer is often cited by papers focused on Glycosylation and Glycoproteins Research (14 papers), Angiogenesis and VEGF in Cancer (12 papers) and Galectins and Cancer Biology (12 papers). Leticia Oliveira‐Ferrer collaborates with scholars based in Germany, Russia and Switzerland. Leticia Oliveira‐Ferrer's co-authors include Volkmar Müller, Karin Milde‐Langosch, Klaus Pantel, Karen Legler, Isabell Witzel, Harriet Wikman, Heidi Schwarzenbach, Barbara Schmalfeldt, Süleyman Ergün and Derya Tilki and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Leticia Oliveira‐Ferrer

75 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leticia Oliveira‐Ferrer Germany 25 1.4k 712 645 458 362 76 2.3k
Angela Platt‐Higgins United Kingdom 24 1.5k 1.1× 724 1.0× 582 0.9× 324 0.7× 261 0.7× 42 2.2k
Sudarshan Anand United States 22 1.1k 0.8× 793 1.1× 726 1.1× 686 1.5× 173 0.5× 44 2.3k
Minji Jo United States 23 1.6k 1.1× 796 1.1× 902 1.4× 444 1.0× 203 0.6× 33 2.5k
María J. Pajares Spain 31 1.4k 1.0× 725 1.0× 621 1.0× 681 1.5× 661 1.8× 60 2.7k
Dorina Belotti Italy 26 1.3k 0.9× 897 1.3× 779 1.2× 213 0.5× 220 0.6× 43 2.4k
Roman Nawroth Germany 24 985 0.7× 577 0.8× 476 0.7× 271 0.6× 601 1.7× 82 2.1k
Yi Fan United States 27 1.3k 1.0× 674 0.9× 629 1.0× 516 1.1× 240 0.7× 64 2.4k
Todd Hembrough United States 25 942 0.7× 880 1.2× 653 1.0× 201 0.4× 524 1.4× 71 2.3k
Marya F. McCarty United States 29 2.0k 1.5× 1.1k 1.6× 869 1.3× 436 1.0× 285 0.8× 37 3.0k
Ying‐Nai Wang United States 24 1.7k 1.2× 955 1.3× 368 0.6× 426 0.9× 420 1.2× 44 2.5k

Countries citing papers authored by Leticia Oliveira‐Ferrer

Since Specialization
Citations

This map shows the geographic impact of Leticia Oliveira‐Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leticia Oliveira‐Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leticia Oliveira‐Ferrer more than expected).

Fields of papers citing papers by Leticia Oliveira‐Ferrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leticia Oliveira‐Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leticia Oliveira‐Ferrer. The network helps show where Leticia Oliveira‐Ferrer may publish in the future.

Co-authorship network of co-authors of Leticia Oliveira‐Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Leticia Oliveira‐Ferrer. A scholar is included among the top collaborators of Leticia Oliveira‐Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leticia Oliveira‐Ferrer. Leticia Oliveira‐Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krüger, Christina, et al.. (2025). Epidermal growth factor receptor specific immunotherapy for SHH medulloblastoma tested in an in vitro blood-brain barrier-model. Cancer Treatment and Research Communications. 44. 100950–100950.
2.
Wolters‐Eisfeld, Gerrit & Leticia Oliveira‐Ferrer. (2024). Glycan diversity in ovarian cancer: Unraveling the immune interplay and therapeutic prospects. Seminars in Immunopathology. 46(6). 16–16. 3 indexed citations
3.
Oliveira‐Ferrer, Leticia, et al.. (2024). Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosis. BMC Cancer. 24(1). 43–43. 2 indexed citations
4.
Loreth, Desirée, Oliver Kretz, Annkathrin Hanssen, et al.. (2024). HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis. Journal of Experimental & Clinical Cancer Research. 43(1). 110–110. 7 indexed citations
5.
Legler, Karen, et al.. (2023). Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer. Journal of Cancer Research and Clinical Oncology. 149(17). 15957–15967. 5 indexed citations
6.
Forcato, Mattia, Giovanni Bertalot, Mattia Barbareschi, et al.. (2023). ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis. Cell Death and Disease. 14(4). 11 indexed citations
7.
Legler, Karen, Thomas Karn, Serenella Eppenberger‐Castori, et al.. (2023). The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients. Cancer Cell International. 23(1). 47–47. 4 indexed citations
8.
Saygı, Ceren, Karen Legler, Christian Gorzelanny, et al.. (2022). Insights into the Steps of Breast Cancer–Brain Metastases Development: Tumor Cell Interactions with the Blood–Brain Barrier. International Journal of Molecular Sciences. 23(3). 1900–1900. 8 indexed citations
9.
Rengsberger, Matthias, Mieczysław Gajda, Lars Jansen, et al.. (2021). CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients. Clinical Epigenetics. 13(1). 15–15. 11 indexed citations
10.
Banys-Paluchowski, Malgorzata, Karin Milde‐Langosch, Tanja Fehm, et al.. (2019). Clinical relevance of H-RAS, K-RAS, and N-RAS mRNA expression in primary breast cancer patients. Breast Cancer Research and Treatment. 179(2). 403–414. 18 indexed citations
11.
Ni, Qingtao, Ines Stevic, Pan Chi, et al.. (2018). Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients. Scientific Reports. 8(1). 12974–12974. 62 indexed citations
12.
Schumacher, Udo, Tobias Lange, Simon A. Joosse, et al.. (2018). Clinical relevance of cytoskeleton associated proteins for ovarian cancer. Journal of Cancer Research and Clinical Oncology. 144(11). 2195–2205. 42 indexed citations
13.
Legler, Karen, Ralph M. Wirtz, Volkmar Müller, et al.. (2018). Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer. British Journal of Cancer. 118(6). 847–856. 52 indexed citations
14.
Maltseva, D. V., Leticia Oliveira‐Ferrer, Karin Milde‐Langosch, et al.. (2017). Selectin-independent adhesion during ovarian cancer metastasis. Biochimie. 142. 197–206. 14 indexed citations
15.
Oliveira‐Ferrer, Leticia, Isabell Witzel, Thomas Karn, et al.. (2015). Relevance of glycosylation-associated genes for tumor progression and metastasis localization in breast cancer. Annals of Oncology. 26. iii15–iii15. 1 indexed citations
16.
Milde‐Langosch, Karin, Leticia Oliveira‐Ferrer, Harriet Wikman, et al.. (2015). Relevance of βGal–βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients. Breast Cancer Research and Treatment. 151(3). 515–528. 30 indexed citations
17.
Oliveira‐Ferrer, Leticia, et al.. (2015). Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function. Molecular and Clinical Oncology. 3(5). 1067–1072. 6 indexed citations
18.
Oliveira‐Ferrer, Leticia, Karl Rössler, Christine Schröder, et al.. (2013). c-FOS suppresses ovarian cancer progression by changing adhesion. British Journal of Cancer. 110(3). 753–763. 74 indexed citations
19.
Tilki, Derya, Ster Irmak, Leticia Oliveira‐Ferrer, et al.. (2006). CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene. 25(36). 4965–4974. 52 indexed citations
20.
Irmak, Ster, Derya Tilki, Jochen Heukeshoven, et al.. (2005). Stage‐dependent increase of orosomucoid and zinc‐alpha 2 ‐glycoprotein in urinary bladder cancer. PROTEOMICS. 5(16). 4296–4304. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Platt‐Higgins Breakdown of academic impact, for papers by Sudarshan Anand Breakdown of academic impact, for papers by Minji Jo Breakdown of academic impact, for papers by María J. Pajares Breakdown of academic impact, for papers by Dorina Belotti Breakdown of academic impact, for papers by Roman Nawroth Breakdown of academic impact, for papers by Yi Fan Breakdown of academic impact, for papers by Todd Hembrough Breakdown of academic impact, for papers by Marya F. McCarty Breakdown of academic impact, for papers by Ying‐Nai Wang
Rankless by CCL
2026